Physician profile
John M Cox
NPI 1669418612
$4,840.78
in general payments reported to CMS, 2019-2025
9 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,240 · 2020: $14.78 · 2022: $2,400 · 2023: $20.46 · 2024: $14.71 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $186.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,212.18 | 2022-2023 | Micra |
| Penumbra, INC. | $2,119.83 | 2019 | |
| Abiomed | $267.92 | 2019-2025 | |
| Shockwave Medical, INC | $175.24 | 2022 | |
| Heartflow, INC. | $19.32 | 2022 | |
| Boston Scientific Corporation | $18.31 | 2025 | Watchman Flx |
| Daiichi Sankyo INC. | $14.71 | 2024 | Injectafer |
| Cardiovascular Systems INC. | $13.27 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.